Movicol

Macrogol 3350, the active ingredient in Movicol, is an osmotic laxative presented as a powder for oral solution (sachet) for oral use. It is prescribed to relieve constipation in adults and children, including chronic and opioid‑induced forms. It combines macrogol with electrolytes to maintain fluid balance while softening stool.

GNH USA supplies Movicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Movicol, an osmotic laxative, is used to treat conditions affecting bowel motility and stool consistency.

- Constipation: alleviates chronic constipation by increasing stool water content and promoting easier passage. - Functional constipation: improves bowel regularity in patients with functional bowel disorders through osmotic action. - Opioid‑induced constipation: counteracts opioid‑related reduction in intestinal motility, restoring normal stool frequency.

Movicol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness in the abdomen. - Nausea: mild feeling of sickness. - Flatulence: increased intestinal gas. - Diarrhea: loose stools occurring more frequently. - Stomach cramps: intermittent abdominal pain. - Thirst: increased desire to drink fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels requiring medical attention. - Dehydration: significant loss of body fluids. - Allergic reaction: rash, itching, swelling, or angioedema. - Severe abdominal pain: intense, persistent pain. - Blood in stool: presence of visible blood in feces.

Before prescribing Movicol, clinicians should consider several safety precautions to minimise risks. - Assess renal function: evaluate kidney performance as reduced clearance may affect electrolyte balance. - Monitor electrolytes: check serum sodium and potassium during prolonged therapy. - Use caution in bowel obstruction: avoid in patients with known mechanical obstruction. - Adjust dose in elderly: start with lower dose due to increased sensitivity. - Review concomitant medications: consider interactions that may alter fluid or electrolyte status. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Movicol can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Other osmotic laxatives: combined use may cause excessive fluid loss and electrolyte disturbances. - Loop diuretics: increased risk of dehydration and electrolyte imbalance. - Lithium: altered lithium plasma concentrations, potentially leading to toxicity. - Anticholinergic agents: may reduce the laxative effect of Movicol.

Moderate Interactions (Monitor Closely): - NSAIDs: concurrent use may affect renal function, enhancing risk of electrolyte abnormalities. - ACE inhibitors: may potentiate changes in potassium levels. - Calcium supplements: can increase risk of constipation, counteracting Movicol’s effect.